Security Snapshot

2SEVENTY BIO INC - COMMON STOCK Institutional Ownership

CUSIP: 901384107

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / COMMON STOCK
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • 901384107 - 2SEVENTY BIO INC - COMMON STOCK is tracked under CUSIP 901384107.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 2 to 1 between Q2 2024 and Q3 2024.
  • Reported value moved from $18,111,008 to $4,997,409.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 901384107?
CUSIP 901384107 identifies 901384107 - 2SEVENTY BIO INC - COMMON STOCK in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of 2SEVENTY BIO INC - COMMON STOCK across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 1,058,773 $4,997,409 +$73,811 $4.72 1
2024 Q2 4,704,158 $18,111,008 -$776,772 $3.85 2
2024 Q1 4,905,917 $26,246,656 +$88,826 $5.35 2
2023 Q4 4,889,314 $20,877,370 $4.27 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .